Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Evaluation of a faecal dysbiosis test for irritable bowel syndrome in subjects with and without obesity

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Managing patients on direct factor Xa inhibitors with rapid thrombelastography

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Plasma glycerol levels in men with hypertriglyceridemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Quantification of biotin in plasma samples by column switching liquid chromatography - tandem mass spectrometry

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Reference intervals for 12 clinical laboratory tests in a Danish population: The Lolland-Falster Health Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Mortality of older acutely admitted medical patients after early discharge from emergency departments: a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Genetic markers of abdominal obesity and weight loss after gastric bypass surgery

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Commentary on "Predictors of Acute Kidney Injury After Hip Fracture in Older Adults"

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Introducing the "hip call" to facilitate early surgical treatment of hip fractures: A feasibility study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Biomarkers for irritable bowel syndrome (IBS) are demanded. An altered faecal microbiome has been reported in subjects with IBS and could be a valuable biomarker. This study evaluated the diagnostic properties of a new test for faecal dysbiosis, designed to distinguish IBS from healthy volunteers and compared the prevalence rates of dysbiosis related to IBS and morbid obesity. Subjects with and without morbid obesity and IBS were included. The faecal microbiota was assessed with GA-mapTM Dysbiosis Test (Genetic Analysis AS, Oslo, Norway). The test result was given as dysbiosis (yes/no). Comparisons were made between four groups: subjects with IBS and morbid obesity (IBS+/MO+); subjects without IBS and with morbid obesity (IBS-/MO+); subjects with IBS and without morbid obesity (IBS+/MO-); and healthy volunteers (IBS-/MO-).The prevalence rates of dysbiosis in the groups IBS+/MO+, IBS-/MO+, IBS+/MO- and IBS-/MO- were 18/28 (64%), 45/71 (63%), 31/63 (49%) and 38/91 (42%). Dysbiosis was more prevalent in subjects with morbid obesity, both in those with and without IBS, than in healthy volunteers (p values .04 and .006). Used as a diagnostic test for IBS in subjects without morbid obesity, the positive and negative likelihood ratios (LR) were 1.18 (0.83-1.67) and 0.87 (0.65-1.18), respectively, and in subjects with morbid obesity the LR were 1.01 (95% CI: 0.73-1.41) and 0.98 (0.54-1.75) respectively. The dysbiosis test was unsuitable as a diagnostic test for IBS. Dysbiosis was statistically significantly associated with morbid obesity, but not with IBS.

Original languageEnglish
JournalScandinavian Journal of Clinical and Laboratory Investigation
Volume78
Issue number1-2
Pages (from-to)109-113
Number of pages5
ISSN0036-5513
DOIs
Publication statusPublished - 2018
Externally publishedYes

    Research areas

  • Adult, Dysbiosis/complications, Feces/microbiology, Female, Humans, Irritable Bowel Syndrome/complications, Male, Middle Aged, Obesity/complications, Prevalence

ID: 56705258